KIORA PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Other
KIORA PHARMACEUTICALS, INC. (KPRX) reported Adjustments to Additional Paid in Capital, Other of -$1.25 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-02-23.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2017-02-23
- KIORA PHARMACEUTICALS, INC. adjustments to additional paid in capital, other for the quarter ending 2015-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. adjustments to additional paid in capital, other for fiscal 2015 was -$1.25M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$1.25M 10-K · filed 2017-02-23 | |
| 2015-09-30 | -$1.25M 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |